EMERGENCY:Trigeminal neuralgia that presents for the first time in a patient under 40, or with accompanying sensory loss, hearing loss, or other cranial nerve deficits, must have MS and posterior fossa tumour excluded by MRI before starting carbamazepine. —call040-46324365immediately — 24 hours, 7 days— 24/7
Expert 3D FIESTA / CISS MRI cisternogram for vascular conflict identification, MS and posterior-fossa tumour exclusion, carbamazepine and oxcarbazepine titration, microvascular decompression (MVD) by the KIMS Neuroscience team with Teflon felt interposition, and stereotactic radiosurgery referral (Gamma Knife / CyberKnife) for unfit patients — at KIMS Neuroscience, Secunderabad, Hyderabad.
Trigeminal neuralgia (TN, tic douloureux) is a disorder of CN V characterised by recurrent, brief, electric-shock facial pain in the V2/V3 distribution triggered by light touch: eating, speaking, brushing teeth, cold wind. The pain is among the most severe experienced by humans. Classical TN (most common): vascular loop compresses CN V root entry zone at the pons — the superior cerebellar artery in most cases. Secondary TN: MS plaque or CP angle tumour at the root entry zone. In India, the most common diagnostic delay is dental: patients have 3–10 teeth extracted in the painful distribution before TN is identified. The distinguishing feature dental pain cannot replicate: TN ends instantaneously, triggered by light skin touch rather than dental pressure. MVD surgery produces complete, lasting pain relief in 80–90% of classical TN patients. 3D FIESTA/CISS MRI cisternogram identifies the offending vascular loop.
| Fact | Details |
|---|---|
| Definition | Paroxysmal electric-shock facial pain in CN V distribution · Triggered by light skin touch (NOT dental pressure) · Ends instantaneously · Pain-free intervals |
| Classical vs secondary | Classical: SCA vascular loop at V root entry zone · Secondary: MS plaque or CP angle tumour · Both require MRI cisternogram |
| 3D FIESTA/CISS | Vendor names: FIESTA (GE), CISS (Siemens), DRIVE (Philips) · Shows vascular conflict at root entry zone · Standard TN protocol at KIMS |
| Medical treatment | Carbamazepine (first-line) + serum sodium monitoring · Oxcarbazepine (fewer interactions) · Pregabalin/lamotrigine/baclofen as add-ons |
| MVD outcomes | 80–90% complete pain relief · 70% maintained at 10 years · Recurrence: 20–30% at 10 years · 5% facial numbness · 2–5% hearing loss |
| MS-related TN | Bilateral TN + young patient + other neurological symptoms: MS workup mandatory · MS plaques at root entry zone on MRI · MVD not appropriate · Carbamazepine + DMT |
| Dental misdiagnosis in India | 3–10 tooth extractions before TGN diagnosis is common in India · Pain in V2/V3 resembles toothache · Light skin touch trigger distinguishes TGN from dental pain |
The essential facts that shape how trigeminal neuralgia is recognised, distinguished from dental pain, and treated at KIMS — from the electric-shock paroxysmal pain in the V2/V3 distribution, to the classical vs secondary classification, the Indian pattern of dental misdiagnosis delays, and the MVD surgery that produces complete pain relief in 80–90% of classical TN patients.
Trigeminal neuralgia (TN, also called tic douloureux — painful tic) is a disorder of the trigeminal nerve (CN V) characterised by recurrent, unilateral, brief, electric shock-like or stabbing facial pain of sudden onset and termination, in one or more divisions of the trigeminal nerve (V1: forehead/eye; V2: cheek/upper teeth; V3: jaw/lower teeth/chin), triggered by innocuous stimuli: light touch to the face, eating, speaking, brushing teeth, and cold wind. The pain is among the most severe experienced by humans — patients describe it as the worst pain imaginable, delivered without warning and stopping as abruptly as it starts.
Classical TN (the most common form): caused by pulsatile compression of the CN V root entry zone at the pons by a vascular loop — most commonly the superior cerebellar artery. The repeated compression gradually demyelinates the root entry zone, producing ectopic discharges that generate the pain. Secondary TN: caused by MS (demyelinating plaque at the CN V root entry zone — suspect in young patients, bilateral TN, or multiple neurological symptoms), cerebellopontine angle tumour, or other structural lesion at the root entry zone. MRI brain with cisternogram is essential in all cases to identify the cause and guide treatment.
Because TN most commonly affects V2 (cheek, upper teeth) and V3 (lower teeth, jaw), the pain is almost universally interpreted as dental in origin, particularly in the early stages when episodes are brief and infrequent. Indian studies consistently document patients with 3–10 extracted teeth in the painful distribution before TN is diagnosed. The critical clinical clue: dental pain does not stop instantaneously — TN pain ends as abruptly as it starts, typically within 2–20 seconds, and is triggered by light touch rather than dental pressure. At KIMS, TN is specifically investigated in any patient with repeated dental procedures without pain resolution.
MVD is a posterior fossa neurosurgical procedure that addresses the cause of classical TN directly — the offending blood vessel is dissected away from the trigeminal nerve root and a small Teflon felt implant is placed between them to prevent re-compression. MVD produces complete pain relief in approximately 80–90% of patients with classical TN, with maintained relief at 10 years in approximately 70%. It is the most effective and most durable treatment for TN in appropriate patients. At KIMS, MVD is performed by the KIMS Neuroscience team using posterior fossa microsurgery.
040-44885000
A 58-year-old retired professor in Hyderabad comes to KIMS with a 4-year history of severe right-sided facial pain. The pain is an electric shock in the right cheek and upper teeth, lasting 2–10 seconds, occurring up to 30–40 times per day. It is triggered by eating (a sip of water, a bite of food), by speaking, and by the touch of a cold breeze on the right cheek. He describes it as the worst pain he has ever experienced — worse than his hip surgery recovery, worse than passing a kidney stone. During a severe episode, he grabs the furniture and cannot speak.
Over 4 years, he has had 9 teeth extracted — the dentist and the patient both assumed the pain was dental because it was felt so strongly in the upper right teeth and cheek. After the ninth extraction, with no teeth remaining on the upper right and the pain completely unchanged, he was referred to a neurologist who diagnosed TN and started carbamazepine. The carbamazepine reduced the pain intensity but produced significant hyponatraemia (low sodium) and cognitive slowing. He is at KIMS because the carbamazepine side effects are affecting his quality of life and he wants to know if surgery is possible.
MRI brain with 3D FIESTA cisternogram at KIMS: a loop of the right superior cerebellar artery is in contact with the CN V root entry zone at the right pons, producing clear vascular compression. No MS plaque, no tumour. Diagnosis: classical TN from superior cerebellar artery compression.
MVD is performed by the KIMS Neuroscience team via a right retrosigmoid craniotomy: the arachnoid is dissected to expose the CN V root entry zone; the offending superior cerebellar artery loop is identified under the operating microscope and gently mobilised away from the nerve root; a Teflon felt implant is placed between the artery and the nerve root to prevent re-compression. Duration: 3 hours. The patient wakes with no facial pain. On day 3: discharged. At 6 weeks: pain-free, off carbamazepine. At 3 years: still pain-free.
Book a Consultation
Speak directly with The KIMS Neuroscience team and the KIMS trigeminal neuralgia specialist team — neurology, neurosurgery, 3D FIESTA / CISS MRI cisternogram protocol, MVD posterior fossa microsurgery, and stereotactic radiosurgery referral coordinated under one roof. No referral required. Monday to Saturday.
040-44885000TN under 40 / cranial nerve deficits: 040-44885000 urgentlyThe clinical profile of trigeminal neuralgia spans the instantaneous-onset, instantaneous-termination electric-shock paroxysmal pain, the light-touch trigger-zone paradox, the refractory periods and fear avoidance behaviour, and the distribution-specific pictures of V2, V3, and V1 TN.
The pain of classical TN has a characteristic quality unlike virtually any other pain: it begins instantaneously and ends instantaneously — an electric shock delivered and withdrawn in 2 to 20 seconds. Between episodes, there is typically no pain at all — the patient is completely comfortable. This paroxysmal pattern (sudden onset, sudden termination, pain-free intervals) is one of the defining diagnostic features. In the early stages, episodes may occur only a few times per day; in severe TN, they occur hundreds of times per day, making eating, drinking, speaking, and dental hygiene impossible.
TN is triggered by light touch to specific areas of the face (trigger zones) — the paradox that severe pain is produced by the most innocuous stimuli: a puff of wind, a sip of water, a finger touching the cheek, a tooth brushing. Heavy pressure (pressing firmly on the cheek) often does not trigger the pain, while the lightest touch triggers a severe paroxysm. This paradox reflects the specific sensitisation of the demyelinated nerve fibres at the root entry zone to normally non-painful tactile inputs (allodynia).
After each paroxysm, there is typically a brief refractory period during which the same trigger does not produce pain. This allows some patients to eat quickly during the refractory period. Between episodes, many TN patients develop profound fear of triggering an attack: they stop eating properly (weight loss is common), stop speaking unless essential, stop brushing their teeth (dental hygiene deteriorates), and stop leaving the house in cold weather. This fear avoidance produces significant secondary malnutrition, depression, and social isolation.
V2 division TN (cheek, upper lip, upper teeth, nose): the most common location, most often triggering dental misdiagnosis. V3 division TN (lower jaw, lower teeth, chin, tongue): second most common, also frequently misdiagnosed as dental. V1 division TN (forehead, eye, scalp): less common; triggers are typically touch to the forehead or eyebrow, wind on the forehead, or cold. V1 TN must prompt consideration of cluster headache (which also produces periorbital pain but with autonomic features and without the electric-shock character) and herpes zoster ophthalmica (if vesicles are present).
Trigeminal neuralgia diagnosis at KIMS combines a high-resolution 3D FIESTA / CISS / DRIVE MRI cisternogram (the vascular-conflict investigation), standard MRI brain with gadolinium to exclude MS plaques and posterior fossa tumours, and a clinical carbamazepine-response test that strongly supports the TN diagnosis when positive.
High-resolution thin-slice 3D MRI sequences (FIESTA on GE systems; CISS on Siemens; DRIVE on Philips) provide exquisite detail of the cisternal segment of CN V and the adjacent vascular structures. Vascular contact with or distortion of the nerve root at the root entry zone is the diagnostic finding of classical TN. At KIMS, this sequence is specifically requested on the MRI brain protocol for TN patients — standard MRI brain sequences may not show the vascular conflict that the cisternogram sequence reveals.
Standard MRI brain with gadolinium: excludes demyelinating plaques (MS), cerebellopontine angle tumours (meningioma, epidermoid, trigeminal schwannoma), and other posterior fossa pathology that can cause secondary TN. Essential in all patients with TN, particularly those under 45 years, those with bilateral symptoms, and those with associated neurological deficits.
A clinical response to carbamazepine (complete or near-complete pain relief at therapeutic doses) is strongly supportive of the TN diagnosis. TN pain responds specifically to sodium channel blockers (carbamazepine, oxcarbazepine) in a way that most other facial pain conditions do not. Failure to respond to adequate carbamazepine doses suggests the diagnosis may not be classical TN and warrants further investigation.
Trigeminal neuralgia treatment at KIMS is built around three integrated pillars — first-line medical therapy with carbamazepine or oxcarbazepine and add-on agents, microvascular decompression by the KIMS Neuroscience team for classical TN with confirmed vascular conflict, and stereotactic radiosurgery referral for patients not fit for MVD or who decline surgery.
Microvascular Decompression (MVD) — Curative Surgical Treatment: MVD is the most effective and most durable treatment for classical TN. At KIMS, MVD is performed by the KIMS Neuroscience team using the retrosigmoid approach: a small craniotomy is made behind the ear; the posterior fossa cistern is opened; the CN V root entry zone is identified under the operating microscope; the offending vessel is gently mobilised away from the nerve root; and a Teflon felt implant is placed to maintain the separation. Outcome: complete pain relief immediately after surgery in approximately 80–90% of patients. Recurrence at 10 years: approximately 20–30%. Complications: hearing loss (2–5%, from manipulation near CN VIII); facial numbness (5–10%); CSF leak (1–2%); meningitis (rare). MVD is preferred for younger patients (under 65–70) with classical TN and confirmed vascular conflict on MRI cisternogram, who are fit for general anaesthesia.
Stereotactic Radiosurgery (Gamma Knife / CyberKnife): For patients who are not fit for surgery or who decline MVD: stereotactic radiosurgery delivers a precisely focused radiation dose to the CN V root entry zone, producing delayed (onset 1–6 months) pain relief in approximately 60–80% of patients. Less effective and less durable than MVD (recurrence more common); but non-invasive, performed as an outpatient, and suitable for elderly or medically unfit patients. Available at specialist centres in Hyderabad; KIMS coordinates referral for appropriate patients.
Carbamazepine 100–400mg three times daily is started at KIMS for newly diagnosed TN pending MRI and surgical assessment. Baseline and 6-month serum sodium and full blood count monitoring is mandatory because of hyponatraemia (particularly in elderly patients) and rare bone marrow suppression and Stevens-Johnson syndrome.
Oxcarbazepine 300–600mg twice daily is often preferred in older patients on multiple medications — similar mechanism, fewer drug interactions, lower rate of haematological side effects. Still causes hyponatraemia at a similar rate to carbamazepine.
Pregabalin, gabapentin, lamotrigine (slow titration), or baclofen (particularly for MS-related TN) are added as second-line agents when carbamazepine is insufficient or poorly tolerated. A lower carbamazepine dose combined with an add-on may produce better pain control with fewer side effects.
Related Conditions
Trigeminal neuralgia belongs to the family of cranial nerve disorders evaluated and managed at KIMS Neuroscience:
Nine teeth extracted and still in pain. Electric shocks triggered by a sip of water. Carbamazepine that makes it possible to function but not fully.
Microvascular decompression (MVD) by the KIMS Neuroscience team, Secunderabad, Hyderabad, addresses the cause — the offending blood vessel at the trigeminal nerve root — and produces complete pain relief in 80–90% of patients. Call 040-44885000 to book a TN assessment.
International enquiries: info@kimsneurosciences.com